Clinical Trial

Guo&'s Distal Entry Tear Repair With WeFlow-EndoPatch System (Gallant Study)

Study acronym: Gallant
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
A Multicenter, Randomized Controlled Study About the Safety and Efficacy of WeFlow-EndoPatch Aortic Endovascular Patch System manufactured by EndoNom Medtech (Hangzhou) Co., Ltd. for Chronic Aortic Dissection . (GALLANT Study)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-18.
Trial Details
NCT Number NCT06945809
Lead Sponsor Hangzhou Endonom Medtech Co., Ltd.
Conditions Aortic Dissection, Distal Entry Tear
Enrollment 204 participants
Start Date 2025-10
Primary Completion 2028-10 (estimated)
Study Completion 2032-10 (estimated)
Updated on ClinicalTrials.gov 2025-04-30